Physicochemical properties of solid dispersions of gliclazide in polyvinylpyrrolidone K90.
作者信息
Biswal S, Sahoo J, Murthy P N
机构信息
Royal College of Pharmacy and Health Sciences, Andhapasara Road, Brahmapur, 760002, Orissa, India.
出版信息
AAPS PharmSciTech. 2009;10(2):329-34. doi: 10.1208/s12249-009-9212-7. Epub 2009 Mar 25.
Abstract
摘要
相似文献
1
Physicochemical properties of solid dispersions of gliclazide in polyvinylpyrrolidone K90.
AAPS PharmSciTech. 2009;10(2):329-34. doi: 10.1208/s12249-009-9212-7. Epub 2009 Mar 25.
2
Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
Acta Pharm. 2009 Mar;59(1):57-65. doi: 10.2478/v10007-009-0001-3.
3
Characterization and solubility study of solid dispersions of flunarizine and polyvinylpyrrolidone.
Farmaco. 2002 Sep;57(9):723-7. doi: 10.1016/s0014-827x(02)01262-4.
4
Solid dispersions of dihydroartemisinin in polyvinylpyrrolidone.
Arch Pharm Res. 2008 Mar;31(3):390-8. doi: 10.1007/s12272-001-1169-6. Epub 2008 Apr 13.
5
Physicochemical investigations and stability studies of amorphous gliclazide.
AAPS PharmSciTech. 2012 Jun;13(2):448-59. doi: 10.1208/s12249-012-9760-0. Epub 2012 Mar 2.
6
Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent.
J Pharm Sci. 2009 Jul;98(7):2422-31. doi: 10.1002/jps.21598.
7
Evaluate the ability of PVP to inhibit crystallization of amorphous solid dispersions by density functional theory and experimental verify.
Eur J Pharm Sci. 2017 Jan 1;96:45-52. doi: 10.1016/j.ejps.2016.08.046. Epub 2016 Aug 25.
8
Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.
J Pharm Pharmacol. 2008 Sep;60(9):1121-9. doi: 10.1211/jpp.60.9.0002.
9
IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
Acta Pol Pharm. 2016 Mar-Apr;73(2):469-78.
10
Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000.
AAPS PharmSciTech. 2008;9(2):563-70. doi: 10.1208/s12249-008-9079-z. Epub 2008 May 6.
引用本文的文献
1
Computational studies for pre-evaluation of pharmacological profile of gut microbiota-produced gliclazide metabolites.
Front Pharmacol. 2024 Dec 3;15:1492284. doi: 10.3389/fphar.2024.1492284. eCollection 2024.
2
Polymer Characteristics for Drug Layering on Particles Using a Novel Melt Granulation Technology, MALCORE.
AAPS PharmSciTech. 2024 Apr 10;25(4):81. doi: 10.1208/s12249-024-02798-7.
3
Physicochemical reports of gliclazide-carplex solid dispersions and tablets prepared with directly compressible co-processed excipients.
Heliyon. 2023 Nov 26;9(12):e22899. doi: 10.1016/j.heliyon.2023.e22899. eCollection 2023 Dec.
4
Mutual Effects of Hydrogen Bonding and Polymer Hydrophobicity on Ibuprofen Crystal Inhibition in Solid Dispersions with Poly(-vinyl pyrrolidone) and Poly(2-oxazolines).
Pharmaceutics. 2021 May 4;13(5):659. doi: 10.3390/pharmaceutics13050659.
5
Preparation of solid dispersion systems for enhanced dissolution of poorly water soluble diacerein: In-vitro evaluation, optimization and physiologically based pharmacokinetic modeling.
PLoS One. 2021 Jan 20;16(1):e0245482. doi: 10.1371/journal.pone.0245482. eCollection 2021.
6
Three-Dimensional (3D)-Printed Zero-Order Released Platform: a Novel Method of Personalized Dosage Form Design and Manufacturing.
AAPS PharmSciTech. 2021 Jan 6;22(1):37. doi: 10.1208/s12249-020-01886-8.
7
Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.
Int J Nanomedicine. 2020 Feb 18;15:1129-1148. doi: 10.2147/IJN.S235290. eCollection 2020.
8
Transport and Biotransformation of Gliclazide and the Effect of Deoxycholic Acid in a Probiotic Bacteria Model.
Front Pharmacol. 2019 Sep 24;10:1083. doi: 10.3389/fphar.2019.01083. eCollection 2019.
9
Novel Gliclazide Electrosprayed Nano-Solid Dispersions: Physicochemical Characterization and Dissolution Evaluation.
Adv Pharm Bull. 2019 Jun;9(2):231-240. doi: 10.15171/apb.2019.026. Epub 2019 Jun 1.
10
Toxicity studies of nanofabricated palladium against filariasis and malaria vectors.
Environ Sci Pollut Res Int. 2018 Jan;25(1):324-332. doi: 10.1007/s11356-017-0428-x. Epub 2017 Oct 15.
本文引用的文献
1
Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000.
AAPS PharmSciTech. 2008;9(2):563-70. doi: 10.1208/s12249-008-9079-z. Epub 2008 May 6.
2
Miscibility behavior and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions.
Drug Dev Ind Pharm. 2005 Jul;31(6):473-89. doi: 10.1080/03639040500215958.
3
Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100.
Drug Dev Ind Pharm. 2004 Mar;30(3):303-17. doi: 10.1081/ddc-120030426.
4
Establishment of new preparation method for solid dispersion formulation of tacrolimus.
Int J Pharm. 2003 Nov 28;267(1-2):79-91. doi: 10.1016/j.ijpharm.2003.07.010.
5
Evaluation of beta-lactose, PVP K12 and PVP K90 as excipients to prepare piroxicam granules using two wet granulation techniques.
Eur J Pharm Biopharm. 2003 Nov;56(3):479-87. doi: 10.1016/s0939-6411(03)00114-0.
6
Influence of polyethylene glycol and povidone on the polymorphic transformation and solubility of carbamazepine.
Int J Pharm. 2002 Jun 20;240(1-2):11-22. doi: 10.1016/s0378-5173(02)00083-2.
7
Studies on solubility and hypoglycemic activity of gliclazide beta-cyclodextrin-hydroxypropylmethylcellulose complexes.
Pharmazie. 2002 Mar;57(3):191-3.
8
Dissolution properties and anticonvulsant activity of phenytoin-polyethylene glycol 6000 and -polyvinylpyrrolidone K-30 solid dispersions.
Int J Pharm. 2001 Aug 28;225(1-2):63-73. doi: 10.1016/s0378-5173(01)00751-7.
9
Modeling and comparison of dissolution profiles.
Eur J Pharm Sci. 2001 May;13(2):123-33. doi: 10.1016/s0928-0987(01)00095-1.
10
Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers.
J Pharm Sci. 2000 Oct;89(10):1325-34. doi: 10.1002/1520-6017(200010)89:10<1325::aid-jps10>3.0.co;2-5.
Zotero 插件